Author Archives: R. Willets Ely

Supreme Court Upholds Federal Circuit’s Full-Scope Enablement Test in Amgen Inc. v. Sanofi

Recently, a unanimous Supreme Court issued its ruling in Amgen Inc. v. Sanofi, holding that Amgen’s challenged patents ran afoul of Section 112’s enablement requirement.

Amici Weigh in on Enablement in Amgen Inc. v. Sanofi

On Friday, February 10, 2023, the latest round of amicus briefs in Amgen Inc. v. Sanofi poured in.  The case, set to be argued on March 27 before the U.S. Supreme Court, asks the Court to wrestle with the enablement requirement of Section 112 of the Patent Act.  Specifically, the Court has been asked to…